113 related articles for article (PubMed ID: 29906496)
1. Screening and characterization of an Annexin A2 binding aptamer that inhibits the proliferation of myeloma cells.
Zhou W; Zhang Y; Zeng Y; Peng M; Li H; Sun S; Ma B; Wang Y; Ye M; Liu J
Biochimie; 2018 Aug; 151():150-158. PubMed ID: 29906496
[TBL] [Abstract][Full Text] [Related]
2. From ugly duckling to swan: unexpected identification from cell-SELEX of an anti-Annexin A2 aptamer targeting tumors.
Cibiel A; Quang NN; Gombert K; Thézé B; Garofalakis A; Ducongé F
PLoS One; 2014; 9(1):e87002. PubMed ID: 24489826
[TBL] [Abstract][Full Text] [Related]
3. Clinical and prognostic role of annexin A2 in multiple myeloma.
Seckinger A; Meissner T; Moreaux J; Depeweg D; Hillengass J; Hose K; Rème T; Rösen-Wolff A; Jauch A; Schnettler R; Ewerbeck V; Goldschmidt H; Klein B; Hose D
Blood; 2012 Aug; 120(5):1087-94. PubMed ID: 22705595
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Annexin II affects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma.
Bao H; Jiang M; Zhu M; Sheng F; Ruan J; Ruan C
Int J Hematol; 2009 Sep; 90(2):177-185. PubMed ID: 19585213
[TBL] [Abstract][Full Text] [Related]
5. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
[TBL] [Abstract][Full Text] [Related]
6. [Apoptosis-inducing effect of annexin A2 on multiple myeloma cells and its related mechanisms].
Bao HY; Wang JN; Hou YQ; Song M; Zhang LB; Meng QQ; Ruan CG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1384-8. PubMed ID: 23257438
[TBL] [Abstract][Full Text] [Related]
7. Hi-Fi SELEX: A High-Fidelity Digital-PCR Based Therapeutic Aptamer Discovery Platform.
Ouellet E; Foley JH; Conway EM; Haynes C
Biotechnol Bioeng; 2015 Aug; 112(8):1506-22. PubMed ID: 25727321
[TBL] [Abstract][Full Text] [Related]
8. Generating lung-metastatic osteosarcoma targeting aptamers for in vivo and clinical tissue imaging.
Wang L; Li P; Xiao X; Li J; Li J; Yang HH; Tan W
Talanta; 2018 Oct; 188():66-73. PubMed ID: 30029428
[TBL] [Abstract][Full Text] [Related]
9. Aptamer selection by high-throughput sequencing and informatic analysis.
Hoon S; Zhou B; Janda KD; Brenner S; Scolnick J
Biotechniques; 2011 Dec; 51(6):413-6. PubMed ID: 22150332
[TBL] [Abstract][Full Text] [Related]
10. Advancements in Aptamer Discovery Technologies.
Gotrik MR; Feagin TA; Csordas AT; Nakamoto MA; Soh HT
Acc Chem Res; 2016 Sep; 49(9):1903-10. PubMed ID: 27526193
[TBL] [Abstract][Full Text] [Related]
11. A simple method for eliminating fixed-region interference of aptamer binding during SELEX.
Ouellet E; Lagally ET; Cheung KC; Haynes CA
Biotechnol Bioeng; 2014 Nov; 111(11):2265-79. PubMed ID: 24895227
[TBL] [Abstract][Full Text] [Related]
12. Aptamer Targeting the ERBB2 Receptor Tyrosine Kinase for Applications in Tumor Therapy.
Mahlknecht G; Sela M; Yarden Y
Methods Mol Biol; 2015; 1317():3-15. PubMed ID: 26072398
[TBL] [Abstract][Full Text] [Related]
13. Refining the Results of a Classical SELEX Experiment by Expanding the Sequence Data Set of an Aptamer Pool Selected for Protein A.
Stoltenburg R; Strehlitz B
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29495282
[TBL] [Abstract][Full Text] [Related]
14. Annexin A2 mediates Mycoplasma pneumoniae community-acquired respiratory distress syndrome toxin binding to eukaryotic cells.
Somarajan SR; Al-Asadi F; Ramasamy K; Pandranki L; Baseman JB; Kannan TR
mBio; 2014 Aug; 5(4):. PubMed ID: 25139904
[TBL] [Abstract][Full Text] [Related]
15. The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.
Hamula CL; Peng H; Wang Z; Newbigging AM; Tyrrell GJ; Li XF; Le XC
J Mol Evol; 2015 Dec; 81(5-6):194-209. PubMed ID: 26538121
[TBL] [Abstract][Full Text] [Related]
16. Tyr23 phosphorylation of Anxa2 enhances STAT3 activation and promotes proliferation and invasion of breast cancer cells.
Yuan J; Yang Y; Gao Z; Wang Z; Ji W; Song W; Zhang F; Niu R
Breast Cancer Res Treat; 2017 Jul; 164(2):327-340. PubMed ID: 28470457
[TBL] [Abstract][Full Text] [Related]
17. Identification of an aptamer through whole cell-SELEX for targeting high metastatic liver cancers.
Rong Y; Chen H; Zhou XF; Yin CQ; Wang BC; Peng CW; Liu SP; Wang FB
Oncotarget; 2016 Feb; 7(7):8282-94. PubMed ID: 26882565
[TBL] [Abstract][Full Text] [Related]
18. A novel Anxa2-interacting protein Ebp1 inhibits cancer proliferation and invasion by suppressing Anxa2 protein level.
Zhang F; Liu Y; Wang Z; Sun X; Yuan J; Wang T; Tian R; Ji W; Yu M; Zhao Y; Niu R
Mol Cell Endocrinol; 2015 Aug; 411():75-85. PubMed ID: 25917452
[TBL] [Abstract][Full Text] [Related]
19. Screening and identification of DNA aptamers against T-2 toxin assisted by graphene oxide.
Chen X; Huang Y; Duan N; Wu S; Xia Y; Ma X; Zhu C; Jiang Y; Wang Z
J Agric Food Chem; 2014 Oct; 62(42):10368-74. PubMed ID: 25265190
[TBL] [Abstract][Full Text] [Related]
20. Absolute quantification of cell-bound DNA aptamers during SELEX.
Avci-Adali M; Wilhelm N; Perle N; Stoll H; Schlensak C; Wendel HP
Nucleic Acid Ther; 2013 Apr; 23(2):125-30. PubMed ID: 23405949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
